Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Adapting the Social-Ecological Framework for Chronic Pain Management and Successful Opioid Tapering.

Wu CA, Simon AJ, Modrich MA, Stacey MW, Matyas BT, Shubrook JH.

J Am Osteopath Assoc. 2019 Dec 1;119(12):793-801. doi: 10.7556/jaoa.2019.132.

PMID:
31790125
2.

Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes.

Chilton RJ, Dungan KM, Shubrook JH, Umpierrez GE.

Prim Care Diabetes. 2019 Nov 5. pii: S1751-9918(19)30075-0. doi: 10.1016/j.pcd.2019.09.008. [Epub ahead of print] Review.

3.

Recruitment effort and costs from a multi-center randomized controlled trial for treating depression in type 2 diabetes.

Myers BA, Pillay Y, Guyton Hornsby W Jr, Shubrook J, Saha C, Mather KJ, Fitzpatrick K, de Groot M.

Trials. 2019 Nov 6;20(1):621. doi: 10.1186/s13063-019-3712-x.

4.

What we know--and don't--about non-nutritive sweeteners.

Dugan J, Chiu JW, Shubrook JH, Young CF.

J Fam Pract. 2019 Jul/Aug;68(6):310-315.

PMID:
31381620
5.

Six-Minute Walk Test as a Predictive Measure of Exercise Capacity in Adults with Type 2 Diabetes.

Nolen-Doerr E, Crick K, Saha C, de Groot M, Pillay Y, Shubrook JH, Donley D, Hornsby WG Jr.

Cardiopulm Phys Ther J. 2018 Jul;29(3):124-129. doi: 10.1097/CPT.0000000000000080.

6.

Program ACTIVE II: Outcomes From a Randomized, Multistate Community-Based Depression Treatment for Rural and Urban Adults With Type 2 Diabetes.

de Groot M, Shubrook JH, Hornsby WG Jr, Pillay Y, Mather KJ, Fitzpatrick K, Yang Z, Saha C.

Diabetes Care. 2019 Jul;42(7):1185-1193. doi: 10.2337/dc18-2400. Epub 2019 May 21.

PMID:
31221693
7.

Primary Raynaud Disease.

Go D, Shubrook JH.

J Am Osteopath Assoc. 2019 Jun 1;119(6):401. doi: 10.7556/jaoa.2019.072. No abstract available.

PMID:
31135869
8.

A visual interactive analytic tool for filtering and summarizing large health data sets coded with hierarchical terminologies (VIADS).

Jing X, Emerson M, Masters D, Brooks M, Buskirk J, Abukamail N, Liu C, Cimino JJ, Shubrook J, De Lacalle S, Zhou Y, Patel VL.

BMC Med Inform Decis Mak. 2019 Feb 14;19(1):31. doi: 10.1186/s12911-019-0750-y.

9.

Food Insecurity Is Associated With Poorer Glycemic Control in Patients Receiving Free Versus Fee-Based Care.

Holben DH, Brown KA, Shubrook JH.

Clin Diabetes. 2019 Jan;37(1):44-48. doi: 10.2337/cd17-0133.

PMID:
30705496
10.

Dry Digital Gangrene.

Shah T, Shubrook JH.

J Am Osteopath Assoc. 2018 Nov 1;118(11):765. doi: 10.7556/jaoa.2018.166. No abstract available.

PMID:
30398575
11.

Evidence for the Prevention of Type 2 Diabetes Mellitus.

Shubrook JH, Chen W, Lim A.

J Am Osteopath Assoc. 2018 Nov 1;118(11):730-737. doi: 10.7556/jaoa.2018.158. Review.

PMID:
30398570
12.

Cardiovascular Disease as a Result of the Interactions Between Obesity, Climate Change, and Inflammation: The COCCI Syndemic.

Clearfield M, Davis G, Weis J, Gayer G, Shubrook JH.

J Am Osteopath Assoc. 2018 Nov 1;118(11):719-729. doi: 10.7556/jaoa.2018.157. Review.

PMID:
30398569
13.

A call to action on prediabetes.

Dugan J, Cantillep A, Newberry K, Shubrook J.

JAAPA. 2018 Oct;31(10):26-30. doi: 10.1097/01.JAA.0000545064.33107.8f. Review.

PMID:
30204618
14.

Time Needed for Diabetes Self-Care: Nationwide Survey of Certified Diabetes Educators.

Shubrook JH, Brannan GD, Wapner A, Klein G, Schwartz FL.

Diabetes Spectr. 2018 Aug;31(3):267-271. doi: 10.2337/ds17-0077.

15.

Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy.

Shubrook JH.

J Fam Pract. 2018 Aug;67(8 suppl):S49-S54. No abstract available.

PMID:
30137054
16.

Diabetes Fellowship in Primary Care: A Survey of Graduates.

Healy AM, Tanenberg RJ, Schwartz FL, Shubrook JH.

J Am Osteopath Assoc. 2018 Aug 1;118(8):538-543. doi: 10.7556/jaoa.2018.122.

PMID:
30073337
17.

Regional Variations in Physical Fitness and Activity in Healthy and Overweight Ecuadorian Adolescents.

Howe CA, Casapulla S, Shubrook JH, Lopez P, Grijalva M, Berryman DE.

Children (Basel). 2018 Aug 2;5(8). pii: E104. doi: 10.3390/children5080104.

18.

Navigating travel with diabetes.

Mullin R, Kruger D, Young CF, Shubrook JH.

Cleve Clin J Med. 2018 Jul;85(7):537-542. doi: 10.3949/ccjm.85a.17105. Review.

19.

Correlations Between A1C and Diabetes Knowledge, Diabetes Numeracy, and Food Security in a Vulnerable Type 2 Diabetes Population.

Young CF, Yun K, Kang E, Shubrook JH, Dugan JA.

Diabetes Spectr. 2018 May;31(2):177-183. doi: 10.2337/ds17-0036.

20.

Endocrinologists' Opinions of Diabetology as a Primary Care Subspecialty.

Healy AM, Shubrook JH, Schwartz FL, Cummings DM, Drake AJ 3rd, Tanenberg RJ.

Clin Diabetes. 2018 Apr;36(2):168-173. doi: 10.2337/cd17-0097.

21.

Cardiovascular Disease and Risk Management: Review of the American Diabetes Association Standards of Medical Care in Diabetes 2018.

Chamberlain JJ, Johnson EL, Leal S, Rhinehart AS, Shubrook JH, Peterson L.

Ann Intern Med. 2018 May 1;168(9):640-650. doi: 10.7326/M18-0222. Epub 2018 Apr 3.

PMID:
29610837
22.

International Classification of Diseases, 10th Revision, Coding for Diabetes.

Dugan J, Shubrook J.

Clin Diabetes. 2017 Oct;35(4):232-238. doi: 10.2337/cd16-0052. No abstract available.

23.

The Time Is Now: Diabetes Fellowships in the United States.

Sadhu AR, Healy AM, Patil SP, Cummings DM, Shubrook JH, Tanenberg RJ.

Curr Diab Rep. 2017 Sep 23;17(11):108. doi: 10.1007/s11892-017-0936-6. Review.

PMID:
28942533
24.

Treatment of Type 1 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.

Chamberlain JJ, Kalyani RR, Leal S, Rhinehart AS, Shubrook JH, Skolnik N, Herman WH.

Ann Intern Med. 2017 Oct 3;167(7):493-498. doi: 10.7326/M17-1259. Epub 2017 Sep 12.

PMID:
28892816
25.

Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 Diabetes.

Valentine V, Goldman J, Shubrook JH.

Diabetes Ther. 2017 Aug;8(4):739-752. doi: 10.1007/s13300-017-0287-y. Epub 2017 Jul 18. Review.

26.

Highlights From the American Diabetes Association's 2017 Standards of Medical Care in Diabetes for Osteopathic Physicians.

Johnson EL, Pfotenhauer K, Bradley S, Kalyani RR, Shubrook JH.

J Am Osteopath Assoc. 2017 Jul 1;117(7):457-472. doi: 10.7556/jaoa.2017.086.

PMID:
28662559
27.

Cardiovascular Disease Risk Factors After an Employer-Based Risk Reduction Program: An Observational Cohort Study.

Holben DH, Rambo C, Howe C, Murray DH, Shubrook JH.

J Am Osteopath Assoc. 2017 Jul 1;117(7):425-432. doi: 10.7556/jaoa.2017.088.

PMID:
28662555
28.

Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.

Umpierrez GE, Bailey TS, Carcia D, Shaefer C, Shubrook JH, Skolnik N.

J Diabetes. 2018 Feb;10(2):94-111. doi: 10.1111/1753-0407.12576. Epub 2017 Aug 25. Review.

PMID:
28581207
29.

Reducing CV risk in diabetes: An ADA update.

Skolnik N, Jaffa FM, Kalyani RR, Johnson E, Shubrook JH.

J Fam Pract. 2017 May;66(5):300-308.

PMID:
28459890
30.

Employer-Funded Complete Health Improvement Program: Preliminary Results of Biomarker Changes.

Remy C, Shubrook JH, Nakazawa M, Drozek D.

J Am Osteopath Assoc. 2017 May 1;117(5):293-300. doi: 10.7556/jaoa.2017.054.

PMID:
28459488
31.

Vitamin D Deficiency, Its Role in Health and Disease, and Current Supplementation Recommendations.

Pfotenhauer KM, Shubrook JH.

J Am Osteopath Assoc. 2017 May 1;117(5):301-305. doi: 10.7556/jaoa.2017.055. Review.

PMID:
28459478
32.

Cardiometabolic risk factors, metabolic syndrome and pre-diabetes in adolescents in the Sierra region of Ecuador.

Casapulla SL, Howe CA, Mora GR, Berryman D, Grijalva MJ, Rojas EW, Nakazawa M, Shubrook JH.

Diabetol Metab Syndr. 2017 Apr 19;9:24. doi: 10.1186/s13098-017-0224-2. eCollection 2017.

33.

Pharmacologic Therapy for Type 2 Diabetes: Synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes.

Chamberlain JJ, Herman WH, Leal S, Rhinehart AS, Shubrook JH, Skolnik N, Kalyani RR.

Ann Intern Med. 2017 Apr 18;166(8):572-578. doi: 10.7326/M16-2937. Epub 2017 Mar 14.

PMID:
28288484
34.

Lifetime Duration of Depressive Disorders in Patients With Type 2 Diabetes.

de Groot M, Crick KA, Long M, Saha C, Shubrook JH.

Diabetes Care. 2016 Dec;39(12):2174-2181. Epub 2016 Oct 11.

35.

Program ACTIVE II: Design and Methods for a Multi-Center Community-Based Depression Treatment for Rural and Urban Adults with Type 2 Diabetes.

de Groot M, Shubrook J, Schwartz F, Hornsby WG Jr, Pillay Y, Saha C.

J Diabetes Res Ther. 2015 Aug;1(2). doi: 10.16966/2380-5544.108. Epub 2015 Aug 5.

36.

Diabetes update: Your guide to the latest ADA standards.

Johnson E, Warren F, Skolnik N, Shubrook JH.

J Fam Pract. 2016 May;65(5):310-8.

PMID:
27275934
37.

Glycated Hemoglobin Testing to Identify Undiagnosed Diabetes Mellitus in the Inpatient Setting.

Jones D, Scharfenberg B, Perkins J, Childers K, Dogbey GY, Shubrook JH.

J Am Osteopath Assoc. 2016 Jun 1;116(6):350-7. doi: 10.7556/jaoa.2016.075.

PMID:
27214771
38.

Effectiveness of the Complete Health Improvement Program in Reducing Risk Factors for Cardiovascular Disease in an Appalachian Population.

Leibold C, Shubrook JH, Nakazawa M, Drozek D.

J Am Osteopath Assoc. 2016 Feb;116(2):84-91. doi: 10.7556/jaoa.2016.020.

PMID:
26830523
39.

A New Method to Assess Asymmetry in Fingerprints Could Be Used as an Early Indicator of Type 2 Diabetes Mellitus.

Morris MR, Ludwar BCh, Swingle E, Mamo MN, Shubrook JH.

J Diabetes Sci Technol. 2016 Jun 28;10(4):864-71. doi: 10.1177/1932296816629984. Print 2016 Jul.

40.

Insulin pumps: Beyond basal-bolus.

Millstein R, Becerra NM, Shubrook JH.

Cleve Clin J Med. 2015 Dec;82(12):835-42. doi: 10.3949/ccjm.82a.14127. Review.

41.

Payer source influence on effectiveness of lifestyle medicine programs.

Vogelgesang J, Drozek D, Nakazawa M, Shubrook JH.

Am J Manag Care. 2015 Sep 1;21(9):e503-8.

42.

Empagliflozin in the treatment of type 2 diabetes: evidence to date.

Shubrook JH, Bokaie BB, Adkins SE.

Drug Des Devel Ther. 2015 Oct 30;9:5793-803. doi: 10.2147/DDDT.S69926. eCollection 2015. Review.

43.

Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals.

Lavernia F, Adkins SE, Shubrook JH.

Postgrad Med. 2015;127(8):808-17. doi: 10.1080/00325481.2015.1085293. Epub 2015 Oct 6. Review.

PMID:
26439384
44.

Clinical Economics Type 2 Diabetes.

Shubrook J.

Med Econ. 2015 Apr 25;92(8):17-8, 20. No abstract available.

PMID:
26298984
45.

Effects of Osteopathic Manipulative Treatment on Diabetic Gastroparesis.

Van Ravenswaay VJ, Hain SJ, Grasso S, Shubrook JH.

J Am Osteopath Assoc. 2015 Jul;115(7):452-8. doi: 10.7556/jaoa.2015.091.

PMID:
26111133
46.

What to do after basal insulin: 3 Tx strategies for type 2 diabetes.

Presswala L, Shubrook J.

J Fam Pract. 2015 Apr;64(4):214-20.

47.

Leveraging the principles of osteopathic medicine to improve diabetes outcomes within a new era of health care reform.

Ciervo CA, Shubrook JH, Grundy P.

J Am Osteopath Assoc. 2015 Apr;115(4 Suppl):eS8-eS19. doi: 10.7556/jaoa.2015.058. Review.

PMID:
25928464
48.

Diabetes management within evolving health care delivery models: the osteopathic perspective.

Ciervo CA, Shubrook JH, Grundy P.

J Am Osteopath Assoc. 2015 Apr;115(4 Suppl):eS5-7. doi: 10.7556/jaoa.2015.057. Review. No abstract available.

PMID:
25928463
49.

Hypoglycemia in Type 2 Diabetes--More Common Than You Think: A Continuous Glucose Monitoring Study.

Gehlaut RR, Dogbey GY, Schwartz FL, Marling CR, Shubrook JH.

J Diabetes Sci Technol. 2015 Apr 27;9(5):999-1005. doi: 10.1177/1932296815581052.

50.

Cutaneous manifestations of diabetes mellitus.

Duff M, Demidova O, Blackburn S, Shubrook J.

Clin Diabetes. 2015 Jan;33(1):40-8. doi: 10.2337/diaclin.33.1.40. No abstract available.

Supplemental Content

Loading ...
Support Center